These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6619037)

  • 1. An azlocillin dosing nomogram for renal insufficiency.
    Whelton A; Stout RL; Delgado FA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():97-9. PubMed ID: 6619037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)].
    Schurig R; Kampf D; Becker H; Förster D
    Arzneimittelforschung; 1979; 29(12a):1944-8. PubMed ID: 543896
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM; Francke EF; Neu HC
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.
    Kampf D; Borner K; Möller M; Kessel M
    Clin Pharmacol Ther; 1984 Feb; 35(2):214-20. PubMed ID: 6319069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of azlocillin in persons with normal and impaired renal functions.
    Fiegel P; Becker K
    Antimicrob Agents Chemother; 1978 Sep; 14(3):288-91. PubMed ID: 708008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis.
    Whelton A; Stout RL; Delgado FA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():89-95. PubMed ID: 6619036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of azlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Weber E
    Eur J Clin Pharmacol; 1982; 22(5):435-9. PubMed ID: 7117356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azlocillin treatment of urinary tract infection in patients on haemodialysis.
    Hallan H; Svarva PL; Svartås TM; Widerøe T
    Scand J Infect Dis Suppl; 1981; 29():55-8. PubMed ID: 6947406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of piperacillin dose on elimination kinetics in renal impairment.
    Aronoff GR; Sloan RS; Brier ME; Luft FC
    Eur J Clin Pharmacol; 1983; 24(4):543-7. PubMed ID: 6222908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of azlocillin in neonates.
    Sitka U; Weingärtner L; Patsch R; Richter I
    Chemotherapy; 1980; 26(3):171-6. PubMed ID: 7363714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temocillin elimination in patients with varying degrees of renal failure.
    Wright N; Wise R; Price JD
    J Antimicrob Chemother; 1983 May; 11(5):481-4. PubMed ID: 6874633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azlocillin serum levels on repetitive dosage in patients with normal and abnormal renal function.
    Wenk M; Follath F
    Chemotherapy; 1986; 32(3):205-8. PubMed ID: 3709269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function.
    Brogard JM; Comte F; Spach MO; Lavillaureix J
    Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Materno-fetal transfer of azlocillin.
    Kafetzis DA; Brater DC; Fanourgakis JE
    J Antimicrob Chemother; 1983 Aug; 12(2):157-62. PubMed ID: 6619053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.